<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82543</article-id><article-id pub-id-type="doi">10.7554/eLife.82543</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>ErbB signalling is a potential therapeutic target for vascular lesions with fibrous component</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-292438"><name><surname>Jauhiainen</surname><given-names>Suvi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292437"><name><surname>Ilmonen</surname><given-names>Henna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292439"><name><surname>Vuola</surname><given-names>Pia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292440"><name><surname>Rasinkangas</surname><given-names>Heta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292441"><name><surname>Pulkkinen</surname><given-names>Heidi H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292442"><name><surname>Keränen</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292443"><name><surname>Kiema</surname><given-names>Miika</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292444"><name><surname>Liikkanen</surname><given-names>Jade J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292445"><name><surname>Laham Karam</surname><given-names>Nihay</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8718-4612</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292446"><name><surname>Laidinen</surname><given-names>Svetlana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-317306"><name><surname>Beter</surname><given-names>Mustafa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292447"><name><surname>Aavik</surname><given-names>Einari</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3018-9521</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292448"><name><surname>Lappalainen</surname><given-names>Kimmo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292449"><name><surname>Lohi</surname><given-names>Jouko</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292450"><name><surname>Aronniemi</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292451"><name><surname>Örd</surname><given-names>Tiit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47163"><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6294-0979</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-13"/><xref ref-type="other" rid="par-14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292452"><name><surname>Salminen</surname><given-names>Päivi</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292453"><name><surname>Tukiainen</surname><given-names>Erkki</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-114570"><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7593-2708</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-16"/><xref ref-type="other" rid="par-18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-131695"><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8556-9727</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="other" rid="par-15"/><xref ref-type="other" rid="par-17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">AI Virtanen Institute for Molecular Sciences</institution>, <institution>University of Eastern Finland</institution>, <addr-line><named-content content-type="city">Kuopio</named-content></addr-line>, <country>Finland</country></aff><aff id="aff2"><institution content-type="dept">Department of Plastic Surgery</institution>, <institution>Helsinki University Hospital</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff3"><institution content-type="dept">Department of Radiology</institution>, <institution>Helsinki University Hospital</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff4"><institution content-type="dept">Department of Pathology</institution>, <institution>Helsinki University Hospital</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff5"><institution content-type="dept">Department of Pediatric Surgery</institution>, <institution>Helsinki University Hospital</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-109584"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing editor</role><aff><institution>Cedars-Sinai Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>johanna.p.laakkonen@uef.fi</email> (JL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>05</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82543</elocation-id><history><date date-type="received"><day>08</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>17</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Jauhiainen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Jauhiainen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82543-v1.pdf"/><abstract><p><bold>Background:</bold> Sporadic venous malformation (VM) and angiomatosis of soft tissue (AST) are benign, congenital vascular anomalies affecting venous vasculature. Depending on the size and location of the lesion, symptoms vary from motility disturbances to pain and disfigurement. Due to high recurrence of the lesions more effective therapies are needed. </p><p><bold>Methods:</bold> As targeting stromal cells has been an emerging concept in anti-angiogenic therapies, here, by using VM/AST patient samples, RNA-sequencing, cell culture techniques and a xenograft mouse model, we investigated the crosstalk of endothelial cells (EC) and fibroblasts and its effect on vascular lesion growth. </p><p><bold>Results:</bold> We report, for the first time, expression and secretion of transforming growth factor A (TGFA) in ECs or intervascular stromal cells in AST and VM lesions. TGFA induced secretion of VEGF-A paracrinally, and regulated EC proliferation. Oncogenic <italic>PIK3CA</italic> variant in p.H1047R, a common somatic mutation found in these lesions, increased TGFA expression, enrichment of hallmark hypoxia, and in a mouse xenograft model, lesion size and vascularization. Treatment with afatinib, a pan-ErbB tyrosine-kinase inhibitor, decreased vascularization and lesion size in mouse xenograft model with ECs expressing oncogenic <italic>PIK3CA</italic> p.H1047R variant and fibroblasts. </p><p><bold>Conclusions:</bold> Based on the data, we suggest that targeting of both intervascular stromal cells and ECs is a potential treatment strategy for vascular lesions having a fibrous component. </p><p><bold>Funding:</bold> Academy of Finland, Ella and Georg Ehnrooth foundation, the ERC grants, Sigrid Jusélius Foundation, Finnish Foundation for Cardiovascular Research, Jane and Aatos Erkko Foundation, and Department of Musculosceletal and Plastic Surgery, Helsinki University Hospital.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source><award-id>328835</award-id><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>ERC grant</institution></institution-wrap></funding-source><award-id>GA670951</award-id><principal-award-recipient><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>ERC grant</institution></institution-wrap></funding-source><award-id>802825</award-id><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Sigrid Jusélius Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Sigrid Jusélius Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Finnish Foundation for Cardiovascular Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Finnish Foundation for Cardiovascular Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Finnish Foundation for Cardiovascular Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Jane and Aatos Erkko Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution>Department of Musculosceletal and Plastic Surgery, Helsinki University Hospital</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Vuola</surname><given-names>Pia</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source><award-id>321535</award-id><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source><award-id>353376</award-id><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source><award-id>287478</award-id><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source><award-id>294073</award-id><principal-award-recipient><name><surname>Kaikkonen</surname><given-names>Minna U</given-names></name></principal-award-recipient></award-group><award-group id="par-15"><funding-source><institution-wrap><institution>Ella and Georg Ehnrooth foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-16"><funding-source><institution-wrap><institution>CoE of Cardiovascular and Metabolic Disease</institution></institution-wrap></funding-source><award-id>307402</award-id><principal-award-recipient><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name></principal-award-recipient></award-group><award-group id="par-17"><funding-source><institution-wrap><institution>GeneCellNano Flagship Program</institution></institution-wrap></funding-source><award-id>337120</award-id><principal-award-recipient><name><surname>Laakkonen</surname><given-names>Johanna P</given-names></name></principal-award-recipient></award-group><award-group id="par-18"><funding-source><institution-wrap><institution>GeneCellNano Flagship Program</institution></institution-wrap></funding-source><award-id>337120</award-id><principal-award-recipient><name><surname>Ylä-Herttuala</surname><given-names>Seppo</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal experiments were approved by National Experimental Animal Board of Finland (Decision No Esavi-2019-004672) and carried out in accordance with guidelines of the Finnish Act on Animal Experimentation.</p></fn><fn fn-type="other"><p>Human subjects: Patient sample collection was approved by the Ethical Committee of the Helsinki University hospital, Helsinki, Finland (Decision No 127/13/03/02/2010 and No 1394/2020). Control sample collection was approved by the Research Ethics Committee of the Northern Savo Hospital District, Kuopio, Finland (Decision No 139/2015). Umbilical cord collection for HUVEC isolation was performed with approval from the Research Ethics Committee of the Northern Savo Hospital District, Kuopio, Finland (Decision No 341/2015). Informed consent, and consent to publish, was obtained from all patients included in the study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data has been submitted to NCBI Gene Expression Omnibus under accession numbers GSE130807 and GSE196311 (GEO reviewer access tokens; wbivkayaxhojdqp and mbehiikgvtmfryh, respectively).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Laakkonen JP</collab><collab>Kaikkonen MU</collab></person-group><year iso-8601-date="2019">2019</year><source>Activation of Epidermal Growth Factor Receptor Pathway in Slow-Flow Vascular Malformations</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130807">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130807</ext-link><comment>NCBI Gene Expression Omnibus, GSE130807</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Laakkonen JP</collab><collab>Kaikkonen MU</collab><collab>Örd T</collab></person-group><year iso-8601-date="2022">2022</year><source>Gene expression profiling of HUVEC-s expressing PIK3CA with H1047R point mutation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196311">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196311</ext-link><comment>NCBI Gene Expression Omnibus, GSE196311</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Kaikkonen MU</collab><collab>Downes N</collab></person-group><year iso-8601-date="2017">2017</year><source>RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins</source><ext-link ext-link-type="uri" xlink:href="/geo/query/acc.cgi?acc=GSE98060">/geo/query/acc.cgi?acc=GSE98060</ext-link><comment>NCBI Gene Expression Omnibus, GSE98060</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-82543-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>